Phase I study of paclitaxel on a 3-hour schedule followed by carboplatin in untreated patients with stage IV non-small cell lung cancer
- 1 June 1997
- journal article
- clinical trial
- Published by Springer Nature in Investigational New Drugs
- Vol. 15 (2) , 129-138
- https://doi.org/10.1023/a:1005821125290
Abstract
This study sought to determine the principal toxicities and feasibility of administering paclitaxel as a 3-hour infusion followed by carboplatin without and with granulocyte colony-stimulating factor...Keywords
This publication has 33 references indexed in Scilit:
- Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors.Journal of Clinical Oncology, 1997
- Paclitaxel cytotoxicity against human lung cancer cell lines increases with prolonged exposure durations.1997
- Prediction of Carboplatin Clearance From Standard Morphological and Biological Patient CharacteristicsJNCI Journal of the National Cancer Institute, 1995
- Further Refinement of Carboplatin DosingJNCI Journal of the National Cancer Institute, 1995
- Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristineZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group ResultsJNCI Journal of the National Cancer Institute, 1993
- Non-small cell lung cancer Part II: TreatmentCurrent Problems in Cancer, 1991
- Results of NCI-sponsored phase I trials with carboplatinCancer Treatment Reviews, 1985
- Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinomaCancer, 1982
- Creatinine Clearance: Bedside EstimateAnnals of Internal Medicine, 1973